2 (1)
2 (2)

Janmed Technolognolognolognolognolognolognolognolognolognologloglogy Co., Ltd. amasangalala kulengeza kuti malonda ake, Tirzepatide, akwanitsa kulembetsa kwa mankhwalawa: 040115) ndipo adalandira kuvomereza kwa FDA pa Ogasiti 2, 2024.

Kupanga Mass Ndi Khadi Lokhazikika

Malinga ndi kasamalidwe kaukadaulo wa jymed, kupanga zochuluka kwa tirzepatide yogwira mankhwala opangira (api) kumatha kufikira magawo a kilogalamu. Ma batchi opanga ndi okhazikika komanso opitiliza, osasinthika pakati pa zingwe, kuwonetsetsa kuti ndi osasinthika.

Zotsatira zazikulu pa shuga ndi kuchepa kwa lipid

Tirzeeatide ndi woyamba kuvomerezedwa ndi Gip / GLP-1 wa Agonist. Monga apolisi a Agonist, amatha kumangapo mabungwe odalira a glucosepic polypeptic (GIP) yolandila ndi 1 receptor mu thupi la munthu. Kuphatikiza pa kuchepa kwa shuga, kumachepetsa kudya kwa chakudya, kunenepa thupi, ndi mafuta ambiri, ndikuwongolera matilid. Kupitilira muyeso wake wotsika wa glucocose komanso wochepetsetsa, kusanthula kwa subgroup kuchokera ku maphunziro a Tirzepatide kumathandizanso kuwonetsa kwa magazi monga kuthamanga kwa magazi, BMI, ndi kuzungulira m'chiuno.

Zikomo kwambiri komanso kulonjeza ziyembekezo

Malinga ndi chidziwitso choyenerera, mounjing-otsika otsika adavomerezedwa koyamba ndi US FDA mu Meyi 2022 zochizira akuluakulu omwe ali ndi matenda a shuga a 2. Pambuyo pake adalandira zovomerezeka mu EU, Japan, ndi zigawo zina. Mu Novembala 2023, FDA inavomerezanso kunenepa kwambiri pansi pa dzina la Brand Zepbound. Mu Meyi 2024, idalowa mu msika waku China. Popeza cholinga chake chogwiritsa ntchito ntchito komanso chothandiza chofufuzira, Tirzekalatide wakhala m'modzi mwa mankhwala otchuka kwambiri masiku ano. Kugulitsa kwake kunafika $ 5.163 biliyoni mu 2023 biliyoni mu 2023, ndipo kotala loyamba la 2024 lokha la 2024, kugulitsidwa biliyoni, kuwonetsa kukula kodabwitsa.

Za eymed

2 (3)

Shenzhen Jymen Technolognolognolognologlognologloglogloglogy Co., Ltd. (PANOFERS yotchulidwa kuti a Jaymed) adakhazikitsidwa mu 2009, pofufuza, kupanga ma peptides ndi malonda okhudzana ndi Peptide. Ndi malo amodzi ofufuza ndi miyeso itatu yayikulu yopanga, a Jaymed ndi amodzi mwa opanga makina okonda kumesi ku China. Gulu la kampani ya R & D limadzitamandira zaka zoposa 20 m'fakitale ya Peptide ndipo yadutsa bwino FDa. Makina okwanira a Jydmed a peptide amapereka makasitomala osiyanasiyana othandizira, kuphatikizapo chitukuko ndi kupanga ma pepputic mapepu, ma antimicrobial mappudes, komanso othandizira komanso othandizira.

Ntchito Zapamwamba Zazikulu

1.

Chitetezo cha zodzikongoletsera

3.Custom Topside ndi Cro, CMO, OEL Services

Mankhwala 4.PDC (peptidide-radioclide, Moleky-Moleky Moleky, Peptidi-Protein, Peptin-RNA)

Kuphatikiza pa Tirzepatide, Eydmet yatumiza zojambula zolembetsa ndi zinthu zina zogulitsa zina zingapo za api, kuphatikizapo mankhwala odziwika omwe amadziwika kuti ndi a GLP-1RRA monga Semaglitide ndi Liraglitide. Makasitomala amtsogolo amagwiritsa ntchito zinthu za a Jydmen adzatha kufotokozera mwachindunji nambala yolembetsa ya CDF kapena nambala ya DMF mukamatumiza mapulogalamu ku FDA kapena CD. Izi zikuchepetsa kwambiri nthawi yokonzekera zikalata zofunsira, komanso nthawi younikira komanso mtengo wa kuwunika kwa malonda.

2 (4)

Lumikizanani nafe

6 (6)
2 (5)

Shenzhen Jymen Technolognolognolognolognologlogy Co., Ltd.

Adilesi:Pansi pa 8 & 9th, Kumanga 1, Shenzhen Biomical Zatsopano ZapamwambaPark, No. 14 Jinhui Road, Kengzi Sladistrict, SIMPHAN CISONI, Shenzhen

Foni:+ 855-26612112

Webusayiti: http://www.jymetch.com/


Post Nthawi: Aug-12-2024
TOP